Figure 2. 2nd MSA patient on nasal foralumab

Figure 2. 2nd MSA patient on nasal foralumab

Marked reduction in Cerebellar white matter uptake following nasal foralumab

Format

PNG

Quelle:

Tiziana Life Sciences Ltd.

Downloads